Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infinity Group is a prominent cross-border private equity and venture capital firm specializing in technology transfer and investment between Israel and China. The firm is best known for its 'i-China' funds, particularly the flagship Infinity I-China Fund, which focuses heavily on the healthcare, biotechnology, and medical device sectors. Infinity Group acts as a strategic bridge, providing growth capital and operational expertise to help international life science companies scale and commercialize their innovations within the Chinese market. The group's healthcare portfolio has included significant early-stage investments in industry leaders such as WuXi AppTec and various innovative medical technology startups. With a robust network of local currency funds across major Chinese hubs, Infinity Group facilitates deep integration with local governments and financial institutions to drive regional high-tech development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infinity i-China.